Search

Displaying results 11 - 20 of 52 in total
  1. Indication

    Stage III Ovarian Epithelial Cancer

    go.drugbank.com/conditions/DBCOND0028510
    Drugs: Bevacizumab
  2. Indication

    Stage III Primary Peritoneal Cancer

    go.drugbank.com/conditions/DBCOND0052103
    Drugs: Bevacizumab
  3. Indication

    Stage IV Ovarian Epithelial Cancer

    go.drugbank.com/conditions/DBCOND0028511
    Drugs: Bevacizumab
  4. Indication

    Recurrent Non-Squamous Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0128059
    Drugs: Bevacizumab
  5. Indication

    Unresectable, advanced Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

    go.drugbank.com/conditions/DBCOND0151382
    Drugs: Bevacizumab
  6. Indication

    Recurrent Glioblastoma

    go.drugbank.com/conditions/DBCOND0033792
    Drugs: Bevacizumab
  7. Indication

    Relapsed Glioblastoma

    go.drugbank.com/conditions/DBCOND0055464
    Drugs: Bevacizumab
  8. Indication

    Recurrent Platinum-Sensitive Epithelial Ovarian Cancer

    go.drugbank.com/conditions/DBCOND0128067
    Drugs: Bevacizumab
  9. Indication

    Recurrent Platinum-resistant Epithelial Ovarian Cancer

    go.drugbank.com/conditions/DBCOND0128069
    Drugs: Bevacizumab
  10. Indication

    Recurrent platinum drug resistant Fallopian tube cancer

    go.drugbank.com/conditions/DBCOND0089459
    Drugs: Bevacizumab